Verily Life Sciences
269 E Grand Avenue
South San Francisco
California
94080
United States
Introducing Verily
92 articles with Verily Life Sciences
-
Verily Appoints Utpal Koppikar as Chief Financial Officer
2/8/2023
Verily, an Alphabet company focused on precision health, announced the appointment of Utpal Koppikar as Chief Financial Officer.
-
Verily Life Sciences, a unit of Alphabet Inc. formerly known as Google Life Sciences, plans to undergo a restructuring that includes cutting about 15% of its workforce and shaking up its C-Suite.
-
This week was rife with Series financings, which channeled money into innovative treatments for immune diseases and cancers, genomic treatments and precision healthcare.
-
The company initiated the use of splenic nerve simulation last month as part of a small clinical trial at the NHS Greater Glasgow & Clyde Health Board in Scotland.
-
Such a deep, data-driven approach is enabling precision medicine, in particular, which is expanding from oncology to autoimmune diseases and other conditions.
-
Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases
1/6/2022
Sosei Group Corporation and Verily, an Alphabet precision health company, announced they have entered into a strategic research collaboration.
-
As 2022 gets underway, multiple companies have already announced partnerships that will advance the potential for new medications in various disease indications.
-
Google's Verily snapped up N.C.-based SignalPath and its clinical trial management system that is expected to support its own clinical trial and evidence-based platform known as Baseline.
-
Temasek has committed $200 million to launch The G2 Bio Companies which focuses on the development of potential next-generation gene therapies.
-
Verily Enhances Commercial Organization with the Appointment of Lisa Greenbaum as Chief Revenue Officer
4/27/2021
Verily, an Alphabet company, announced the appointment of Lisa Greenbaum to the newly-created role of chief revenue officer.
-
In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.
-
Verily, Google/Alphabet’s life sciences company, raised $700 million in an invest round that included Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.
-
Cognizant Collaborates on Verily's Nationwide Baseline COVID-19 Testing Program
6/23/2020
Cognizant announced it is collaborating with Verily Life Sciences, the health and life sciences company of Alphabet, to facilitate COVID-19 testing across the U.S.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 19, 2020.
-
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression
2/26/2020
RECOVER sub-study will leverage Verily research tools to provide quantitative assessment measures of depressive episodes
-
The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.
-
The BioSpace Ideal Employer Report examined aspects regarding the importance of culture within life sciences organizations.
-
Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Devices
2/4/2020
Santen Pharmaceutical Co., Ltd. (Head office: Osaka, hereinafter “Santen”) and Verily, an Alphabet company, announced the establishment of a joint venture※ focused on applying microelectronics and scalable digital technologies to ophthalmology.
-
Here’s a look at the top 10 companies noted in the BioSpace Ideal Employer 2019 survey for being the most innovative and what they’ve been up to recently.
-
Earlens Announces Partnership with Verily to Develop Next-Generation Capabilities for Earlens® Contact Hearing Solution
1/13/2020
Earlens Corporation, a medical technology company that has created the world's first nonsurgical hearing solution that directly vibrates the eardrum, announced that they have entered into a strategic agreement with Verily, an Alphabet company, to develop next-generation capabilities for the Earlens® Contact Hearing Solution.